Chemoinformaics analysis of 4-O-beta-D-Glucopyranosyl-D-mannose
| Molecular Weight | 342.297 | nRot | 8 |
| Heavy Atom Molecular Weight | 320.121 | nRig | 7 |
| Exact Molecular Weight | 342.116 | nRing | 1 |
| Solubility: LogS | 0.306 | nHRing | 1 |
| Solubility: LogP | -2.799 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 0 |
| nHetero | 11 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 11 | No. of Arom Bond | 0 |
| nHA | 11 | APOL | 43.5314 |
| nHD | 8 | BPOL | 26.4106 |
| QED | 0.209 |
| Synth | 4.476 |
| Natural Product Likeliness | 2.027 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.043 |
| Pgp-sub | 0.866 |
| HIA | 0.822 |
| CACO-2 | -5.964 |
| MDCK | 0.000269665 |
| BBB | 0.303 |
| PPB | 0.134007 |
| VDSS | 0.291 |
| FU | 0.703344 |
| CYP1A2-inh | 0.008 |
| CYP1A2-sub | 0.013 |
| CYP2c19-inh | 0.006 |
| CYP2c19-sub | 0.049 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.054 |
| CYP2d6-inh | 0 |
| CYP2d6-sub | 0.071 |
| CYP3a4-inh | 0.003 |
| CYP3a4-sub | 0.003 |
| CL | 1.045 |
| T12 | 0.871 |
| hERG | 0.29 |
| Ames | 0.075 |
| ROA | 0.006 |
| SkinSen | 0.047 |
| Carcinogencity | 0.004 |
| EI | 0.019 |
| Respiratory | 0.006 |
| NR-Aromatase | 0.005 |
| Antiviral | Yes |
| Prediction | 0.898439 |